MTX pathway gene variants, erythrocyte methotrexate polyglutamates, and treatment outcomes in rheumatoid arthritis
Rheumatoid arthritis (RA) exhibits significant inter-patient variability in response to and toxicity from methotrexate (MTX). The clinical utility of erythrocyte methotrexate polyglutamates (MTXPGs) and MTX-pathway pharmacogenetics remains uncertain. This study investigates the relationships betwee...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2026-01-01
|
| シリーズ: | Biomolecules & Biomedicine |
| 主題: | |
| オンライン･アクセス: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/13544 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|